Dr. John Buse, MD (he/him) is an Endocrinologist in Chapel hill, NC with over 18 years of experience. What is your opinion of Dr. John Buse, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. John Buse, MD has received over $484,053 which includes payments from the following companies:
$255,881.32 from Novo Nordisk AS
$74,960.37 from ELI LILLY AND COMPANY
$70,197.55 from Novo Nordisk Inc
$17,870.31 from Merck Sharp & Dohme Corporation
$15,692.62 from Boehringer Ingelheim International GmbH
$14,360.84 from MannKind Corporation
$7,763.29 from CSL Behring
$7,594.20 from AstraZeneca Pharmaceuticals LP
$3,750.00 from Zealand Pharma A/S
$3,549.17 from Dexcom, Inc.
$3,403.54 from sanofi-aventis U.S. LLC
$3,000.00 from LILLY USA, LLC
$2,809.04 from F. Hoffmann-La Roche AG
$2,154.98 from AstraZeneca UK Limited
$816.00 from Takeda Development Center Americas, Inc.
$250.00 from GlaxoSmithKline, LLC.
Payments received by Dr. John Buse, MD were from the following categories:
$264,384.04 Consulting Fee
$183,512.18 Travel and Lodging
$14,673.98 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!